Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Allergan v. Staar Surgical

This article was originally published in The Gray Sheet

Executive Summary

Allergan v. Staar Surgical: Allergan reports June 16 that a jury in the U.S. District Court for the Central District of California has determined that Microtech and Allergan are the "owner and exclusive licensee, respectively" of U.S. patent No. 4,681,102, which covers the "Bartell Shooter" instrument and a method for inserting intraocular lenses into the eye during cataract surgical procedures. Allergan filed suit in November 1992 seeking "injunctive relief and compensatory and treble damages resulting from willful infringement" by Staar, which claimed ownership of the patent ("The Gray Sheet" Nov. 30, 1992, p. 16). The jury found that neither Staar nor Chiron, which has a sublicense to the patent from Staar, has any rights to the Bartell invention. "As a result of this verdict, we intend to vigorously pursue our claims of willful infringement against Staar and Chiron," Allergan says...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel